Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Genuine Parts Company (GPC) vs Marsh & McLennan Companies, Inc. (MRSH) Price & Performance

Genuine Parts CompanyTrade
Marsh & McLennan Companies, Inc.Trade

Price performance (Past 24H)

Key statistics

Genuine Parts Company vs Marsh & McLennan Companies, Inc. — how do they compare? Genuine Parts Company trades at $126.76 (market cap $17.67B), while Marsh & McLennan Companies, Inc. trades at $176.52 (market cap $84.31B). The key difference: Marsh & McLennan Companies, Inc. is far larger — about 4.8× Genuine Parts Company's market cap, and Genuine Parts Company pays the higher dividend (3.32%). Which is the better fit depends on your goals — on Pluang, investors hold Genuine Parts Company for 75 Days and Marsh & McLennan Companies, Inc. for 109 Days on average.

GPCMRSH
Market Cap
$17.67B$84.31B
Volume
1,079,4583,948,947
Sector
Consumer CyclicalFinancials
52-Week High
$149.26$207.02
52-Week Low
$92.47$157.32
Typical Hold Time
75 Days109 Days
Enterprise Value
$23.76B$104.99B
Dividend Yield
3.32%2.24%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Genuine Parts Company

GPC trades at $125.41, down 1.55% on the day, with a bearish technical signal and mixed fundamentals. The company reported Q2 2026 EPS of $2.15, beating expectations, but net income margin remains thin at 0.13%. Analyst consensus is mixed with 43% buy ratings and a $145.75 price target. The planned Q1 2027 separation of automotive and industrial businesses represents a key catalyst, though profitability concerns persist amid declining cash flow trends.

The outlook remains cautious with near-term pressure from weak technicals and margin compression, balanced by potential upside from the corporate split. Key risks include execution of the separation, competitive pressures in auto parts distribution, and macroeconomic sensitivity. The stock offers value at current levels for investors betting on successful restructuring, but requires careful monitoring of Q3 earnings due October 20, 2026.

Marsh & McLennan Companies, Inc.

Marsh (MRSH) trades at $173.66, up 1.11% today, with a bullish technical signal despite mixed moving averages and oscillators. The company shows strong fundamentals, with revenue growing to $26.98B in 2025 and net income of $4.16B, supported by consistent earnings beats. Recent news highlights the completion of the Accel Holdings acquisition, potentially enhancing its advisory services footprint. Valuation ratios include a P/E of 21.57 and ROE of 25.72%, indicating solid profitability.

The outlook for MRSH is positive, driven by earnings momentum and strategic acquisitions, but risks include high debt levels and competitive pressures. Analysts maintain a consensus price target of $202.71, suggesting upside potential, though the majority recommend Hold. Investors should weigh growth opportunities against execution risks and market volatility.

Returns comparison

Trailing returns across standard periods

About Genuine Parts Company

Genuine Parts sells automotive parts (about two thirds of net sales) and industrial components. The company sells vehicle parts to commercial and retail customers through roughly 9,700 stores worldwide, most of which are independently owned. Its industrial unit, primarily operating under the Motion Industries banner in the United States, supplies bearings, power transmission, industrial automation, hydraulic, and pneumatic components to maintenance, repair, and OEM clients.

Read more on GPC →

About Marsh & McLennan Companies, Inc.

Marsh & McLennan Companies Inc is a professional services firm that provides advice and solutions in the areas of risk, strategy, and human capital. The company operates through two main segments: risk and insurance services and consulting. In risk and insurance services, the firm offers services via Marsh (an insurance broker) and Guy Carpenter (a risk and reinsurance specialist). The consulting division comprises Mercer (a provider of human resource services) and Oliver Wyman (management and economic consultancy).

Read more on MRSH →